Search results
Quebec to become 1st province to offer free RSV shots for infants
CBC via Yahoo News· 6 days agoQuebec will offer a one-dose antibody to help protect babies and vulnerable children against...
CCMB, Aganitha to apply Generative AI for therapeutic design, research
Investing.com· 1 day agoCCMB, a part of the Council of Scientific & Industrial Research (CSIR), and Aganitha, which combines...
New immunotherapy could treat cancer in the bone, study suggests
PA Media: Science via Yahoo News· 14 hours agoA new type of immunotherapy could help to treat bone cancer, new research suggests. Developed by UCL...
Jacksonville research group seeks participants for new COVID-19 vaccine trial
WJXT Jacksonville· 8 hours agoResearchers at the Jacksonville Center for Clinical Research (JCCR) are recruiting people to...
ASCO: J&J's radioligand spurs responses, but 4 deaths mar early results
FierceBiotech· 6 days agoJohnson & Johnson’s radiopharmaceutical spurred “profound and durable” responses, however, four...
Drinking unpasteurized raw milk containing bird flu viruses may be dangerous, new study finds
Salon via Yahoo News· 1 day agoCows in a meadow Getty Images/VLIET A new study published in the New England Journal of Medicine...
SOTIO Biotech doses first subject in Phase I solid tumour treatment trial
Clinical Trials Arena via Yahoo Finance· 21 hours agoLast October, SOTIO entered a licence and option deal with Synaffix, a Lonza company, for developing...
Fannin launches Radiomer Therapeutics with novel targeting vector/ligand platform for...
PRWeb· 19 hours agoRadiomer has a rich pipeline of assets in development with lead programs expected to complete Phase 0 imaging/dosimetry trial(s) in cancer patients in Q1 2025. "Raptamers combine antibody ...
Annual General Meeting in Cantargia AB
Digital Journal· 6 days agoAbout CantargiaCantargia AB (publ), reg. no. 556791-6019, is a biotechnology company that develops antibody-based treatments for life-threatening diseases and has established ...
FDA accepts Sanofi’s Sarclisa sBLA for priority review
Pharmaceutical Technology via Yahoo Finance· 2 days agoSanofi is seeking approval for Sarclisa, a monoclonal antibody, in combination with bortezomib,...
